Data as of Dec 19
| +1.73 / +3.15%|
The 8 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 60.00, with a high estimate of 81.00 and a low estimate of 48.00. The median estimate represents a +5.84% increase from the last price of 56.69.
The current consensus among 8 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.